Venus Optics recently unveiled the Laowa Magic Shift Converter (MSC) for Sony Full Frame E-mount cameras. The Laowa Magic Shift Converter is a lens adapter built with a patented optics system, which expands the image circle of the ultra-wide angle lenses. The shift mechanism on the adapter takes advantage of the enlarged image circle and shifts the camera sensor along the axis. The MSC is specially designed for the Laowa 12mm f/2.8 Zero-D lens and it converts the lens into a 17mm f/4 Zero-D lens with +/- 10mm shift capability. It comes with a close-to-zero distortion feature. Additionally, the MSC comes with a 360° rotation structure which allows the user to shoot in both horizontal and portrait orientation. The lens structure includes 5 elements in 4 groups. Its dimensions are 69.6 x 44.1mm and weighs about 360g. The Laowa Magic Shift Converter's Canon variant is currently available on the official website of Venus Optics (http://www. venuslens.net/) and their authorized resellers. The shipment of its Nikon variant is expected in two months.
Toshiba Corp. on July 11 had a meeting with its main banks about the negotiation of the sale of its semiconductor memory business with the Japan-US-South Korea ally led by Innovation Network Corp. of Japan (INCJ). The top management of Toshiba explained the negotiation is stalemated because the ally has a difficulty on the roles of SK Hynix of South Korea, which seems to have a stronger interest in NAND type flash memory technology than the other have earlier expected because SK is behind Samsumg in the mass production for NAND memory while it has know-how in DRAM production, which lacks in Toshiba and thinks the company has a merit to join the ally and commit to Toshiba Memory’s production more aggressively. Toshiba revealed it has started to negotiate again with Western Digital and Hon Hai Precision. WD has proposed the acquisition by allying with U.S. fund Kohlberg Kravis Roberts (KKR & Co.), INCJ and Development Bank of Japan. Toshiba wants to decide the sale of Toshiba Memory by the end of March, 2018 in order to have excessive liabilities two years in a row which is to lead to the company going private.
Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.